Evolving Brachytherapy Boost in Prostate Cancer in the Era of Hypofractionation
Int J Radiat Oncol Biol Phys
.
2020 Nov 15;108(4):914-916.
doi: 10.1016/j.ijrobp.2020.08.028.
Authors
Neil B Desai
1
,
Aurelie Garant
2
,
Raquibul Hannan
2
,
Michael R Folkert
2
Affiliations
1
Department of Radiation Oncology, University of Texas Southwestern, Dallas, Texas. Electronic address:
[email protected]
.
2
Department of Radiation Oncology, University of Texas Southwestern, Dallas, Texas.
PMID:
33069353
DOI:
10.1016/j.ijrobp.2020.08.028
No abstract available
Publication types
Editorial
Comment
MeSH terms
Brachytherapy*
Humans
Male
Prospective Studies
Prostate-Specific Antigen
Prostatic Neoplasms* / radiotherapy
Radiation Dose Hypofractionation
Substances
Prostate-Specific Antigen